Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer
- 1 September 2002
- Vol. 60 (3) , 22-30
- https://doi.org/10.1016/s0090-4295(02)01564-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A phase III trial comparing whole-pelvic (WP) to prostate only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS): preliminary analysis of RTOG 9413International Journal of Radiation Oncology*Biology*Physics, 2001
- Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancerUrology, 2001
- RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- 5 Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy. A phase III EORTC studyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Treatment of Advanced Localised Prostatic Cancer by Orchiectomy, Radiotherapy, or Combined Treatment. A Medical Research Council StudyBritish Journal of Urology, 1992
- Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long-term results of a prospective randomized studyInternational Journal of Radiation Oncology*Biology*Physics, 1988